13G Filing: Amzak Capital Management, Llc and Zosano Pharma Corp (NASDAQ:ZSAN)

CUSIP No. 98979H103

SCHEDULE 13G

Item 1(a).

Name of Issuer:
ZOSANO PHARMA CORPORATION

Item 1(b).

Address of Issuers Principal Executive Offices:
34790 Ardentech Court, Fremont, CA 94555

Item 2(a).

Name of Person Filing:
This Schedule 13G is being file by each of the following persons (each a Reporting Person and together, the Reporting Persons):

(i)            Amzak Capital Management, LLC (Amzak);

(ii)           Michael D. Kazma (MK); and

(iii)          Gerry Kazma (GK).

See Exhibit A for the Reporting Persons agreement for a joint filing of a single statement on their behalf.

Item 2(b).

Address of Principal Business Office:
The address of the principal business office of each Reporting Person is 980 N. Federal Highway, Suite 315, Boca Raton, FL 33432.

Item 2(c).

Citizenship:

Amzak was organized under the laws of the State of Nevada.

Each of MK and GK is a citizen of Canada.

Item 2(d).

Title of Class of Securities:
Common Stock, par value $0.0001 per share (Common Stock).

Item 2(e).

CUSIP Number:
98979H103

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.